Back

The 2020 U.S. cancer screening deficit and the timing of adults' most recent screen: A population-based quasi-experiment

2022-06-27 public and global health Title + abstract only
View on medRxiv
Show abstract

In 2020, cancer screenings declined, then rebounded, resulting in a cancer screening deficit. The significance of this deficit, however, has yet to be quantified from a population health perspective. Our study addresses this evidence gap by examining how the pandemic changed the timing of American adults most recent cancer screen. We obtained population-based, cancer screening data from the Behavioral Risk Factor Surveillance System. Mammograms, pap smears, and colonoscopies were each specified ...

Predicted journal destinations